Related Experiment Video
Updated: May 1, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Fungal infections in cancer patients
1Division of Infectious Disease, Northwestern University Feinberg School of Medicine, 645 N. Michigan Ave, Suite 900, Chicago, IL, 60611, USA, m-angarone@northwestern.edu.
Abstract:
Invasive fungal infections (IFI) have become a leading cause of morbidity and mortality in cancer patients. Infections with these organisms are often difficult to diagnose and treat. Appropriate and timely diagnosis requires a high index of suspicion and invasive procedures, including biopsy, to confirm the diagnosis. Treatment may be difficult, secondary to variable susceptibility and difficulty with exact and specific characterization of the fungal pathogen. The pathogens that are seen range from yeasts to invasive molds. Fortunately newer, noninvasive diagnostic techniques are available to aid in the diagnosis and treatments have become better tolerated and more efficacious.
Insights
Invasive fungal infections (IFI) pose significant risks to cancer patients, often presenting diagnostic and treatment challenges. Advances in noninvasive techniques and therapies are improving outcomes for these serious infections.
Area of Science:
- Mycology
- Oncology
- Infectious Diseases
Background:
- Invasive fungal infections (IFI) are a major cause of illness and death in cancer patients.
- Diagnosing and treating IFIs can be complex due to pathogen variability and diagnostic challenges.
Purpose of the Study:
- To highlight the challenges in diagnosing and treating invasive fungal infections in cancer patients.
- To introduce advancements in diagnostic and therapeutic strategies for IFIs.
Main Methods:
- Review of current diagnostic and treatment modalities for IFIs in oncology.
- Discussion of emerging noninvasive diagnostic techniques.
- Evaluation of newer, more effective antifungal treatments.
Main Results:
- IFI diagnosis often requires invasive procedures and a high index of suspicion.
- Pathogen identification can be difficult, impacting treatment selection.
- Newer noninvasive diagnostic tools are becoming available.
- Current treatments are better tolerated and more effective.
Conclusions:
- Early and accurate diagnosis of IFIs is critical for cancer patient outcomes.
- Advancements in diagnostics and therapeutics are improving the management of IFIs.
- Continued research into noninvasive methods and novel treatments is essential.
Related Concept Videos
Fungal Phylum Microsporidia
Antifungal Agents
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Tumor Immunotherapy

